Clinical Trial Update: The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT [NA]

View source ↗

Summary

A prospective randomized trial comparing a new-generation bioresorbable scaffold to a drug-coated balloon for de novo large coronary artery lesions; currently n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Bioresorbable scaffold (new-generation) (bioresorbable scaffold)
• drug-coated balloon

Snippet

Sponsor: Xuzhou Third People's Hospital | Conditions: Coronary Artery Disease(CAD), de Novo Coronary Lesions | NA | Status: NOT_YET_RECRUITING